Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rong-Fu Wang

Showing results (81-90 of 144) with videos related to

Pageof 15
Sort By:
Science Translational Medicine|December 10, 2025
ZAP327 signaling domain-driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse modelsXin Liu, Jiayi Zhang, Junjun Chu, et al.
Frontiers in Immunology|January 9, 2019
Cancer Stem Cells and Immunosuppressive Microenvironment in GliomaQianquan Ma, Wenyong Long, Changsheng Xing, et al.
Frontiers in Oncology|October 29, 2020
PHF20 Promotes Glioblastoma Cell Malignancies Through a <i>WISP1</i>/<i>BGN</i>-Dependent PathwayQianquan Ma, Wenyong Long, Changsheng Xing, et al.
Cell Research|December 25, 2013
USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptorsJun Cui, Yanxia Song, Yinyin Li, et al.
Brain Research|September 7, 2010
Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranesJin Wu, Jun Toyohara, Yuko Tanibuchi, et al.
International Journal of Clinical and Experimental Medicine|May 2, 2015
Detection of pulmonary metastases with the novel radiolabeled molecular probe, (99m)Tc-RRLNing Yao, Ping Yan, Rong-Fu Wang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 20, 2011
[(131)I labeling and bioactivity evaluation of a novel RGD dimer targeted to integrin αvβ3 receptor]Chun-li Zhang, Rong-fu Wang, Li Zhang, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 19, 2015
Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive PromoterLing Li, Chun-li Zhang, Lei Kang, et al.
Molecular Cell|October 4, 2016
USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination through NLRP4 SignalosomeMeng Lin, Zhiyao Zhao, Zhifen Yang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|August 19, 2015
[Efficiency evaluation of diuretic renography in the operative or conservative treatments of unilateral ureteropelvic junction obstruction patients]Meng Liu, Zhan-li Fu, Li-juan Di, et al.
Pageof 15

Showing results (81-90 of 144) with videos related to

Sort By:
Pageof 15
Science Translational Medicine|December 10, 2025
ZAP327 signaling domain-driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse modelsXin Liu, Jiayi Zhang, Junjun Chu, et al.
Frontiers in Immunology|January 9, 2019
Cancer Stem Cells and Immunosuppressive Microenvironment in GliomaQianquan Ma, Wenyong Long, Changsheng Xing, et al.
Frontiers in Oncology|October 29, 2020
PHF20 Promotes Glioblastoma Cell Malignancies Through a <i>WISP1</i>/<i>BGN</i>-Dependent PathwayQianquan Ma, Wenyong Long, Changsheng Xing, et al.
Cell Research|December 25, 2013
USP3 inhibits type I interferon signaling by deubiquitinating RIG-I-like receptorsJun Cui, Yanxia Song, Yinyin Li, et al.
Brain Research|September 7, 2010
Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranesJin Wu, Jun Toyohara, Yuko Tanibuchi, et al.
International Journal of Clinical and Experimental Medicine|May 2, 2015
Detection of pulmonary metastases with the novel radiolabeled molecular probe, (99m)Tc-RRLNing Yao, Ping Yan, Rong-Fu Wang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|April 20, 2011
[(131)I labeling and bioactivity evaluation of a novel RGD dimer targeted to integrin αvβ3 receptor]Chun-li Zhang, Rong-fu Wang, Li Zhang, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 19, 2015
Enhanced EJ Cell Killing of (125)I Radiation by Combining with Cytosine Deaminase Gene Therapy Regulated by Synthetic Radio-Responsive PromoterLing Li, Chun-li Zhang, Lei Kang, et al.
Molecular Cell|October 4, 2016
USP38 Inhibits Type I Interferon Signaling by Editing TBK1 Ubiquitination through NLRP4 SignalosomeMeng Lin, Zhiyao Zhao, Zhifen Yang, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|August 19, 2015
[Efficiency evaluation of diuretic renography in the operative or conservative treatments of unilateral ureteropelvic junction obstruction patients]Meng Liu, Zhan-li Fu, Li-juan Di, et al.
Pageof 15